| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_283c3294b52dc7ec6b88039fbc7be613 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-03 |
| filingDate |
2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50fc2d097e440d4954edd206b338e313 |
| publicationDate |
2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005082001-A2 |
| titleOfInvention |
Advanced isothiazole based protein kinase inhibitors |
| abstract |
Hydroxy containing isothiazole base derivatives have enhanced and unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10011593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9868726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3184525-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650366-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10633373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9353093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9371314-B2 |
| priorityDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |